I believe all the short term revenues on the 9/30/16 balance sheet become recognized in 1st Q 2017. So sales for the current quarter should be substantial.
Another, dating back to November was just released a couple of days prior. I cant help but wonder if Dr.Khan's arrival has any connection to Nicole Richters appointment, after her 16 years at BASF...?